| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0093 | 1 |